23 March 2020
Novosibirsk’s Vector Institute, which has developed a prototype of the coronavirus vaccine, will test it first on the most sensitive lab animals – lower primates and ferrets, Vector Institute Deputy Chairwoman on Research Yelena Gavrilova said on TV.
Earlier reports indicated that Vector has developed a prototype coronavirus vaccine. Now, it will be tested on the sensitive lab animals. It would allow determining the most effective dosage, frequency and administration method of the vaccine.
“Currently, we have both vaccines based on known recombinant viruses and synthetic vaccine, developed on six separate technological platforms. We have already began experiments on animal lab models. Immediately after we got our hands on the living virus, we conducted studies on getting sensitive lab models, which turned out to be ferrets and lower primates. Now that we have vaccine prototypes, we test them on the lab animals,” Gavrilova said.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024